{"data":{"id":"us-md/md.-code-insurance-15-850","jurisdiction":"us-md","citation":"Md. Code, Insurance § 15–850","heading":"","body":"(a) In this section, “opioid antagonist” means:\n(1) naloxone hydrochloride; or\n(2) any other similarly acting and equally safe drug approved by the federal Food and Drug Administration for the treatment of a drug overdose.\n(b) (1) This section applies to:\n(i) insurers and nonprofit health service plans that provide coverage for prescription drugs under individual, group, or blanket health insurance policies or contracts that are issued or delivered in the State; and\n(ii) health maintenance organizations that provide coverage for prescription drugs under individual or group contracts that are issued or delivered in the State.\n(2) An insurer, a nonprofit health service plan, or a health maintenance organization that provides coverage for prescription drugs through a pharmacy benefits manager is subject to the requirements of this section.\n(c) An entity subject to this section that includes on its formulary an opioid antagonist may apply a prior authorization requirement for an opioid antagonist only if the entity provides coverage for at least one formulation of the opioid antagonist without a prior authorization requirement.","path":["Article - Insurance"],"source_url":"https://mgaleg.maryland.gov/mgawebsite/Laws/StatuteText?article=gin\u0026section=15-850","current_through":"2026-01-01","vintage":"","retrieved_at":"2026-09-14T19:59:28Z","sha256":"9274cd0e586051e8202963b2f8cc4095fc9ac9d86fc2bb8fb93a958b9e4fbb34","source_id":"us-md","stale":false,"prev":"us-md/md.-code-insurance-15-849","next":"us-md/md.-code-insurance-15-851"},"notice":"GroundRules: Original legal text. Not legal advice."}